Skip to content
Sign in

Business opportunities

Who each startup should sell to, sell through, build with, enter a market with or raise from, read from the whole network. Every opportunity comes with its reasoning, the evidence and a first step.

SWC 2026 Finalist

Love Lifesciences

Physician-led Kansas medtech developing UniPen, a universal vial-compatible self-injection pen aimed at cutting pharma device costs and lead times.

Open the dossier
Opportunities
5
High confidence
070% and above
Counterparts
5startups and investors
  • Co-development 2
  • Investors 2
  • Peers 1

Co-development2

An integration or joint product

Early device partnership for injectable nanobody formulations

Nanogrow develops nanobody biologics with an injectable route among others and is still preclinical, the phase when device choices are cheapest to make. Co-developing a vial-plus-UniPen presentation gives Love Lifesciences a first biologic programme and Nanogrow a low-cost self-administration option.

20%confidence

Evidence from the records

  • “Nanobody (sdAb) platform combined with local delivery formulations: topical, nebulized, injectable, oral or via DNA/RNA.”
  • “UniPen universal injector pen compatible with standard vials, for self-administration of drugs.”
If it works
A letter of intent naming UniPen as the candidate device for one programme, useful for both companies' fundraising.
First step
Share UniPen's viscosity/volume envelope with Nanogrow's formulation team.

Explore lower-cost manufacturing through Byonyks' Pakistan factory

Byonyks runs a regulator-approved device factory in Pakistan and has cleared a class II home-therapy device with the FDA. A contract-manufacturing or know-how arrangement could cut UniPen's unit cost and accelerate regulatory documentation; Byonyks fills factory capacity.

20%confidence

Evidence from the records

  • “DRAP-approved factory in Pakistan”
  • “FDA 510(k) clearance K243371 (decision of 16 May 2025, class II)”
  • “reduce costs and lead times for pharmaceutical companies”
If it works
A manufacturing quote and regulatory-pathway mentoring that de-risk the FDA plan.
First step
Ask Byonyks for its contract-manufacturing capabilities and ISO certification scope.

Investors2

A fund whose thesis fits

Pitch Robin Hood Ventures via Vytala Health

Robin Hood Ventures is a US angel network investing $0.25–0.5M at pre-seed/seed in HealthTech and life sciences, matching Love Lifesciences' stage. It led Vytala Health's round in the network, providing a warm introduction.

35%confidence

Evidence from the records

  • “Robin Hood Ventures (lead), Delaware Crossing Investment Group, Ulu Ventures, The MBA Fund, JumpStart NJ, business angel groups”
  • “~$1.2M (WIBW); $1.72M over 5 rounds according to CB Insights”
If it works
A seed cheque to fund the FDA pathway.
First step
Ask Vytala Health's founders for an introduction to Robin Hood Ventures' screening lead.

Use PharmStars' pharma network to land a first partner

PharmStars invests at pre-seed/seed in HealthTech and life sciences globally and is oriented to pharma partnerships, addressing Love Lifesciences' main gap (no pharma partner). It led Cromodata's round in the network.

30%confidence

Evidence from the records

  • “PharmStars Ventures (lead), Sancus Capital, Gabriela Pittis (business angel)”
  • “UniPen available through licensed pharmacies (not FDA-authorized); no pharma customer or partner named.”
If it works
Investment plus introductions to pharma device teams.
First step
Ask Cromodata's CEO for an intro to PharmStars and prepare a pharma-facing value proposition.

Peers1

Founders solving the same problem elsewhere

Share FDA and QMS learnings between two pre-clearance drug-delivery devices

Both companies are pre-FDA drug-delivery device makers founded by clinicians. Sharing regulatory consultants, QMS templates and test labs reduces cost for both.

25%confidence

Evidence from the records

  • “No public evidence of traction found: pump shown as a concept visual; funds intended for R&D, clinical validation and the FDA pathway.”
  • “High risk: regulatory (FDA), competition from BD/Ypsomed and little capital.”
If it works
Lower regulatory preparation costs through shared vendors.
First step
Set a call between the two founders to compare FDA pathway plans.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai

Most promising across the network

587 opportunities analysed
  1. VenditekwithPulster.aiCo-development
    Use Pulster NOVA to place and price every new machine

    Vending profitability is a location game, and Pulster sells site assessment and cannibalisation models to 49 Latin American retail brands from the same country. Venditek gets data-driven placement; Pulster gets a new micro-format use case and a joint offer to its retail clients.

    50%
  2. Piezo Sonic CorporationwithProxima RoboticsCo-development
    Run Proxima Compass on Mighty AMR

    Piezo Sonic's differentiation is the rough-terrain chassis and drive, not fleet software; Proxima sells a hardware-agnostic navigation and flow-management layer to robot makers. Bundling Compass on Mighty AMR gives Piezo a proven European navigation stack and gives Proxima an outdoor, all-terrain reference platform beyond indoor AGVs.

    50%
  3. Proxima RoboticswithPiezo Sonic CorporationCo-development
    Port Compass to Piezo Sonic's all-terrain AMR

    Piezo Sonic builds rough-terrain AMRs and sells through Japanese trading houses; Proxima sells navigation software. A port opens outdoor robotics and an Asian channel for Proxima.

    45%
  4. Thistle OÜwithOmniLoc AICo-development
    Integrate GPS-free localisation into Thistle Shield

    Counter-drone engagements happen where GPS is jammed or spoofed, often by the defender itself. OmniLoc's camera-to-satellite matching keeps autonomous platforms positioned without GPS, a direct building block for Thistle's autonomy and a field deployment for OmniLoc.

    40%
  5. RegenratewithFarmbookerCo-development
    Satellite monitoring of contracted fields

    Regenrate guarantees a price before sowing, so it carries yield risk across 1,000+ ha; satellite monitoring of each contracted field improves forecasting and agronomic support. Farmbooker supplies that layer.

    40%
  6. GreenirrwithLayrzCo-development
    Use Layrz's device-agnostic IoT cloud as the data-ingestion layer

    Greenirr needs telematics data from heterogeneous devices; Layrz already normalises many device brands through an API. An integration lets Greenirr onboard fleets in Latin America without custom connectors, and Layrz adds emissions analytics for its asset-tracking customers.

    40%
  7. IKI HealthwithHormonyCo-development
    Combine Hormony's saliva hormone kit with IKI prescriptions

    Menopause programmes need objective hormone data, which Hormony sells as a saliva kit; IKI turns data into clinician-prescribed programmes. A combined test-to-programme offer is stronger for both and opens cross-distribution between Spain and Hormony's markets.

    40%
  8. KetzaiwithMaria EducaçãoCo-development
    Plan-assess loop: Ketzai planning + Maria assessment

    Ketzai produces lesson plans; Maria Educação diagnoses student performance and builds learning paths for publishers and municipalities. Linking assessment results to lesson planning closes the loop that ministries buy, and gives Maria a Spanish-speaking entry route through Ketzai's teacher base.

    40%
  9. Starko OnewithPromptendCo-development
    Verify every Starko PR with deterministic checks

    Starko's promise is a verified pull request, and trust in AI code is the adoption bottleneck. Promptend checks behaviour of AI-generated TypeScript against a spec deterministically, a direct building block that strengthens Starko's claim and gives Promptend a distribution channel.

    40%
  10. ORA TechnologieswithThirdRocCo-development
    Plug ThirdRoc's pay-per-decision credit agents into the super-app

    Embedded credit is the main profit pool of a super-app, but ORA has no documented scoring capability. ThirdRoc sells AI credit decisioning, fraud detection and KYC paid per decision, which fits a variable-cost launch with a licensed Moroccan lender. ThirdRoc gains a North African deployment beyond Fiji.

    40%
  11. aimea.aiwithCoachbot AiCo-development
    From interview evidence to onboarding coaching

    aimea produces documented skills evidence at hiring; Coachbot turns coaching methodologies into AI coaching for HR/L&D. Passing aimea's gap analysis into a CoachBot onboarding plan creates a hire-to-develop offer for the same HR buyer, both Berlin/Hamburg-based.

    35%
  12. BelliwithLayrzCo-development
    Feed IoT asset telemetry into cargo status messaging

    Belli generates and parses IATA status messages; Layrz runs a device-agnostic IoT cloud for vehicles and assets. Wiring Layrz telematics (trucks, dollies, ULD trackers) into Belli's ontology would automate FSU-type status events and give carriers real-time visibility without manual scans, a feature legacy CMS vendors sell as costly add-ons.

    35%
  13. CromodatawithHardshellCo-development
    Certify datasets as leak- and poison-free

    Buyers of AI training data will require assurance against re-identification and contamination. Hardshell scans datasets for these risks; a 'verified' label increases Cromodata's price and trust.

    35%
  14. TerraSparkwithAstrolightCo-development
    Co-develop optical pointing and ground stations for power beaming

    Laser-based power beaming needs the same acquisition, pointing and tracking chain and ground-station know-how that Astrolight has flown. Astrolight gains a second application for its optical stack, while TerraSpark de-risks the transmission link with flight-proven hardware.

    35%
  15. Pleryon TherapeuticswithOcuwell LimitedCo-development
    Portable corneal imaging as a dry-eye trial endpoint

    Pleryon's dry-eye trial needs objective ocular-surface measures; Ocuwell's portable corneal topography device is already used by clinicians. Using OCUTOP in Pleryon's trial sites gives Pleryon richer endpoints and Ocuwell a pharma-trial use case.

    35%
  16. PraxilabswithHi DoctorCo-development
    Joint 'basic science to bedside' simulation bundle for medical schools

    Medical faculties buy both lab simulation (physiology, biochemistry) and clinical-reasoning simulation; PraxiLabs covers the first, Hi Doctor's AI virtual patients the second. A bundled offer raises deal size per faculty and gives each a reference in the other's region (MENA vs Central Asia).

    35%
  17. ProcureProwithSLZCo-development
    Turn MEP design models into procurement packages automatically

    MEP packages are among the most complex and costly to procure, especially on data centres and fabs. SLZ automates MEP design and maintains BIM-based digital twins; feeding SLZ quantities and routing into ProcurePro would pre-populate tender packages and track installed versus committed scope.

    35%
  18. PromptendwithStarko OneCo-development
    Verification gate in an AI feedback-to-PR pipeline

    Starko's AI builds accepted product changes all the way to a verified pull request; Promptend checks that generated TypeScript matches its spec. Embedding Promptend as Starko's verification step strengthens Starko's 'verified PR' promise and gives Promptend a production integration.

    35%
  19. Nanogrow BiotechwithLegit.HealthCo-development
    Use Legit.Health AI scoring as trial endpoints in psoriasis and AD

    Dermatology trials depend on severity scores that are subjective and costly to collect. Legit.Health provides CE-marked automated scoring and already partners with dermatology pharma, which could make Nanogrow's early trials cheaper and more credible to licensees.

    35%
  20. Viz Ai TechnologywithEthermindCo-development
    Capture retiring experts as AI twins on the shop floor

    Viz Ai's core thesis is the 'silver wave' of retiring mechanics; Ethermind builds AI twins of an organisation's best experts. Combining Viz Ai's in-job capture with Ethermind's knowledge-twin engine gives dealers a structured expertise base, not just repair logs.

    35%

Similar profiles

Compatibility score with Love Lifesciences

Scored on needs and offers, market bridge, customer potential, sector synergy and stage. Open a profile to see each dimension.